Patient dies following muscular dystrophy gene therapy, Sarepta reports
The young man died of acute liver injury, a known side effect, Sarepta said in a statement. But the company said the ...
Yahoo Finance3d
Patient dies following muscular dystrophy gene therapy, Sarepta reports
WASHINGTON (AP) — Sarepta Therapeutics (SRPT ... scientists about its effectiveness in treating Duchenne muscular dystrophy. It’s the first gene therapy approved in the U.S. for the rare ...
Yahoo Finance3d
Sarepta Therapeutics Reports Patient Death Post Elevidys Gene Therapy Treatment, Stock Plunges
On Tuesday, Sarepta Therapeutics ... moxeparvovec-rokl), the only approved gene therapy in patients with Duchenne muscular dystrophy. The company reported a patient death following treatment ...
The Hamilton Spectator4d
Patient dies following muscular dystrophy gene therapy, Sarepta reports
WASHINGTON (AP) — Sarepta Therapeutics said Tuesday that a patient died while taking its closely watched gene therapy for muscular dystrophy, sending company shares plummeting more than 25%.
Investopedia3d
Sarepta Therapeutics Stock Sinks After Company Says Patient Taking Its Drug Dies
Piotr Swat / SOPA Images / LightRocket via Getty Images Sarepta Therapeutics said a patient taking its treatment for Duchenne muscular dystrophy has died from acute liver failure. The ...
FiercePharma3d
Sarepta reports one death after patient received DMD gene therapy Elevidys
One patient with Duchenne muscular dystrophy (DMD) has passed away following treatment with Sarepta Therapeutics’ gene therapy Elevidys, the biotech said (PDF) Tuesday. The patient suffered ...
Parkersburg News and Sentinel3d
Patient dies following muscular dystrophy gene therapy
WASHINGTON (AP) — Sarepta Therapeutics said Tuesday that ... scientists about its effectiveness in treating Duchenne muscular dystrophy. It’s the first gene therapy approved in the U.S ...